Previous studies have shown that overexpression of EGFR promotes chemoresistance in cancer cells (12), and that EGFR-mediated activation of the MAPK and PI3K pathways can be observed following chemotherapy exposure (13, 14). This evidence concerns the gene EGFR and cancer.